September 1, 2015 — Automated alerts for excess fluid accumulation in the lungs did not improve outcomes for heart ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
August 28, 2015 — BioControl Medical said it has completed enrollment in its INOVATE-HF (INcrease Of VAgal TonE in Heart ...
August 18, 2015 — Sunshine Heart Inc. announced an update in late July on its COUNTER HF U.S. pivotal study for the C ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
August 11, 2015 — HeartWare International Inc. announced that enrollment in the ENDURANCE2 destination therapy clinical ...
August 7, 2015 — Mayo Clinic is announcing results of a study on the effectiveness of left ventricular assist devices ...
August 6, 2015 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers, patients and caregivers ...
August 5, 2015 — HeartWare expanded the Class I recall of its ventricular assist device in mid-June due to concerns over ...
August 4, 2015 — Over the past several years, advanced heart failure patients who have not responded to medical therapy ...
August 3, 2015 — Sunshine Heart announced plans to commence a first-in-human study using its novel C-Pulse ...
July 29, 2015 — A new clinical trial to test how a high dose of stem cells delivered via a method called retrograde ...
July 22, 2015 — Heart failure patients had a significantly lower chance of being readmitted within 30 days of discharge ...
July 22, 2015 — St. Jude Medical and Thoratec announced that the boards of directors of both companies have unanimously ...
July 17, 2015 - NeoStem Inc. presented updated efficacy and safety results from the one-year follow-up for its Phase 2 ...
July 6, 2015 - DC Devices Inc. announced that it has completed enrollment and implants in the REDUCE LAP-HF trial, an ...
June 30, 2015 - Sunshine Heart Inc. has borrowed an additional $2 million to continue work on its U.S. pivotal study for ...